Meyka Pro banner
Natera, Inc.

Natera, Inc. (NTRA) Stock Overview

Explore Natera, Inc.’s financial performance, market position, analyst ratings, and future outlook.

NTRA●NASDAQ
HealthcareMedical - Diagnostics & Research
$414.52
$2.75(0.67%)
U.S. Market opens in 16h 18m

Natera, Inc. (NTRA)

Meyka AI Score

Z

Key Financials

Market Cap59.4B
P/E Ratio-302.02
EPS (TTM)$-1.32
ROE-0.12%
Fundamental Analysis

AI Price Forecasts

1 Month$447.62
3 Months$339.07
1 Year Target$253.91

NTRA Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Natera, Inc. (NASDAQ: NTRA) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Natera, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of NTRA on the NASDAQ shows an RSI of 82.80, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $253.91 for the NASDAQ listing.

Key metrics behind Natera, Inc.'s NASDAQ-traded stock include a P/E ratio of -302.02 and a market capitalization of 59.4B. Combined with our AI analysis, these give both institutional and retail investors a clear view of NTRA on the NASDAQ.

Price Performance (NASDAQ: NTRA)

1-Day Change
0.67%
5-Day Change
6.15%
1-Month Change
27.05%
3-Month Change
52.22%
6-Month Change
126.95%
Year-to-Date (YTD) Change
80.94%
1-Year Change
154.17%
3-Year Change
836.77%
5-Year Change
285.17%
All-Time (Max) Change
2202.89%

Contact Information

650 249 9090
13011 McCallen Pass Building A, Austin, TX, 78753

Company Facts

61,380 Employees
IPO DateJul 1, 2015
CountryUS
Actively Trading

Frequently Asked Questions